Injective (INJ) is trading around $6.7760 on the 1d timeframe. Its 50 EMA sits at $7.5599 and its 200 EMA at $6.2936, so the moving-average structure is bullish — the 50 EMA is above the 200 EMA (golden-cross territory). Price is below the 50 EMA (-11.57%) and above the 200 EMA (+7.12%). In an uptrend the 50 EMA often acts as dynamic support; in a downtrend, as dynamic resistance. These values recompute continuously — open the live EMA scanner for the up-to-the-minute structure across every timeframe.
Open the live EMA scanner →| Metric | Value | Price vs. EMA |
|---|---|---|
| 50 EMA | $7.5599 | -11.57% |
| 200 EMA | $6.2936 | 7.12% |
| Structure | Golden-cross (bullish) | |
| TF | 50 EMA | 200 EMA | Structure | Recent cross |
|---|---|---|---|---|
| 1d | $7.5599 | $6.2936 | Golden-cross (bullish) | — |
| 4h | $7.8195 | $7.7577 | Golden-cross (bullish) | — |
| 1w | $6.6551 | $9.6554 | Death-cross (bearish) | — |
See INJ support & resistance levels →
On the 1d timeframe, Injective (INJ) is currently in a golden cross (the 50 EMA above the 200 EMA, bullish), with the 50 EMA at $7.5599 and the 200 EMA at $6.2936.
INJ's 50-period EMA on the 1d timeframe is around $7.5599; price is currently -11.57% from it.
INJ is currently above its 200 EMA ($6.2936), about 7.12% above.
A golden cross is when a shorter moving average (here the 50 EMA) crosses above a longer one (the 200 EMA), often read as a bullish momentum shift. The opposite — the 50 crossing below the 200 — is a death cross.